The global market for novel weight-loss drugs like Novo Nordisk A/S's Ozempic and Wegovy is poised to reach $100 billion by 2035 as patients start to understand the efficacy of the medications.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
